Ascent Group LLC Purchases Shares of 55,268 Haleon PLC Sponsored ADR $HLN

Key Points

• Ascent Group LLC has invested approximately $569,000 in Haleon PLC Sponsored ADR by acquiring 55,268 shares during the 1st quarter of 2023.
• Haleon recently announced a new semi-annual dividend of $0.0555 per share, reflecting an increase from its previous $0.05 dividend.
• The stock has received various upgrades from analysts, with Goldman's rating moving from "neutral" to "buy" and the consensus rating currently at "Moderate Buy" with a target price of $12.33.

Ascent Group LLC bought a new stake in Haleon PLC Sponsored ADR (NYSE:HLN - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 55,268 shares of the company's stock, valued at approximately $569,000.

Other large investors also recently bought and sold shares of the company. Bartlett & CO. Wealth Management LLC lifted its position in Haleon by 135.9% in the first quarter. Bartlett & CO. Wealth Management LLC now owns 2,588 shares of the company's stock valued at $27,000 after buying an additional 1,491 shares during the last quarter. Banque Transatlantique SA acquired a new stake in shares of Haleon during the first quarter worth about $27,000. Opal Wealth Advisors LLC acquired a new stake in shares of Haleon during the first quarter worth about $29,000. Deutsche Bank AG lifted its position in shares of Haleon by 267.8% during the first quarter. Deutsche Bank AG now owns 3,126 shares of the company's stock worth $32,000 after purchasing an additional 2,276 shares in the last quarter. Finally, Continuum Advisory LLC lifted its position in shares of Haleon by 152.4% during the first quarter. Continuum Advisory LLC now owns 4,753 shares of the company's stock worth $49,000 after purchasing an additional 2,870 shares in the last quarter. Institutional investors and hedge funds own 6.67% of the company's stock.

Analyst Ratings Changes

HLN has been the topic of several research reports. BNP Paribas Exane raised shares of Haleon from a "neutral" rating to an "outperform" rating and set a $13.40 price target on the stock in a research report on Tuesday, May 27th. The Goldman Sachs Group raised shares of Haleon from a "neutral" rating to a "buy" rating in a research report on Wednesday, September 10th. Barclays cut shares of Haleon from an "overweight" rating to an "equal weight" rating in a research report on Tuesday. BNP Paribas raised shares of Haleon to a "strong-buy" rating in a research report on Tuesday, May 27th. Finally, Wall Street Zen cut shares of Haleon from a "buy" rating to a "hold" rating in a research report on Saturday, July 12th. Two research analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $12.33.

Haleon Stock Down 4.1%

Shares of HLN stock traded down $0.40 during trading hours on Tuesday, reaching $9.29. 7,007,664 shares of the stock were exchanged, compared to its average volume of 12,449,140. The business's fifty day moving average is $9.72 and its two-hundred day moving average is $10.20. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.87 and a quick ratio of 0.63. Haleon PLC Sponsored ADR has a 12-month low of $8.86 and a 12-month high of $11.42. The firm has a market capitalization of $41.56 billion, a P/E ratio of 23.81, a P/E/G ratio of 2.90 and a beta of 0.23.

Haleon Increases Dividend

The company also recently announced a semi-annual dividend, which will be paid on Thursday, September 18th. Investors of record on Friday, August 15th will be paid a dividend of $0.0555 per share. The ex-dividend date is Friday, August 15th. This is a positive change from Haleon's previous semi-annual dividend of $0.05. This represents a dividend yield of 190.0%. Haleon's payout ratio is currently 28.21%.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.